Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melander

Showing results (711-720 of 1,704) with videos related to

Pageof 171
Sort By:
Science Translational Medicine|December 3, 2020
Evidence for a protective role of placental growth factor in cardiovascular diseaseYihong Chen, Anna Hultgårdh Nilsson, Isabel Goncalves, et al.
Angewandte Chemie (International Ed. in English)|March 2, 2017
The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase InhibitorsT Vu Nguyen, Meghan S Blackledge, Erick A Lindsey, et al.
International Journal of Obesity (2005)|December 24, 2010
Association between fat intake, physical activity and mortality depending on genetic variation in FTOE Sonestedt, B Gullberg, U Ericson, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Synthesis and biological evaluation of 2-aminoimidazole/carbamate hybrid anti-biofilm and anti-microbial agentsSteven A Rogers, Erick A Lindsey, Daniel C Whitehead, et al.
The Journal of Clinical Endocrinology and Metabolism|April 15, 2011
Plasma copeptin, a unifying factor behind the metabolic syndromeSofia Enhörning, Joachim Struck, Elisabet Wirfält, et al.
Lakartidningen|May 12, 2021
[Precision medicine in complex diseases]Erik Melén, Bo Jacobsson, Mikael Benson, et al.
European Journal of Endocrinology|October 28, 2015
Genetic vasopressin 1b receptor variance in overweight and diabetes mellitusSofia Enhörning, Marketa Sjögren, Bo Hedblad, et al.
Diabetes|November 1, 1993
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDMC Saloranta, M R Taskinen, E Widen, et al.
Scandinavian Journal of Public Health|February 2, 2006
Neighborhood social participation, use of anxiolytic-hypnotic drugs, and women's propensity for disability pension: a multilevel analysisKristina Johnell, Nils-Ove Månsson, Jan Sundquist, et al.
The Journal of Organic Chemistry|January 10, 2009
Antibiofilm activity of a diverse oroidin library generated through reductive acylationT Eric Ballard, Justin J Richards, Arianexys Aquino, et al.
Pageof 171

Showing results (711-720 of 1,704) with videos related to

Sort By:
Pageof 171
Science Translational Medicine|December 3, 2020
Evidence for a protective role of placental growth factor in cardiovascular diseaseYihong Chen, Anna Hultgårdh Nilsson, Isabel Goncalves, et al.
Angewandte Chemie (International Ed. in English)|March 2, 2017
The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β-Lactam Antibiotics in a Pattern Distinct from β-Lactamase InhibitorsT Vu Nguyen, Meghan S Blackledge, Erick A Lindsey, et al.
International Journal of Obesity (2005)|December 24, 2010
Association between fat intake, physical activity and mortality depending on genetic variation in FTOE Sonestedt, B Gullberg, U Ericson, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2011
Synthesis and biological evaluation of 2-aminoimidazole/carbamate hybrid anti-biofilm and anti-microbial agentsSteven A Rogers, Erick A Lindsey, Daniel C Whitehead, et al.
The Journal of Clinical Endocrinology and Metabolism|April 15, 2011
Plasma copeptin, a unifying factor behind the metabolic syndromeSofia Enhörning, Joachim Struck, Elisabet Wirfält, et al.
Lakartidningen|May 12, 2021
[Precision medicine in complex diseases]Erik Melén, Bo Jacobsson, Mikael Benson, et al.
European Journal of Endocrinology|October 28, 2015
Genetic vasopressin 1b receptor variance in overweight and diabetes mellitusSofia Enhörning, Marketa Sjögren, Bo Hedblad, et al.
Diabetes|November 1, 1993
Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDMC Saloranta, M R Taskinen, E Widen, et al.
Scandinavian Journal of Public Health|February 2, 2006
Neighborhood social participation, use of anxiolytic-hypnotic drugs, and women's propensity for disability pension: a multilevel analysisKristina Johnell, Nils-Ove Månsson, Jan Sundquist, et al.
The Journal of Organic Chemistry|January 10, 2009
Antibiofilm activity of a diverse oroidin library generated through reductive acylationT Eric Ballard, Justin J Richards, Arianexys Aquino, et al.
Pageof 171